Previous close | 5.3900 |
Open | 5.0500 |
Bid | 3.6000 x 200 |
Ask | 6.0600 x 200 |
Day's range | 4.6900 - 5.1300 |
52-week range | 4.5000 - 9.9350 |
Volume | |
Avg. volume | 67,009 |
Market cap | 272.727M |
Beta (5Y monthly) | 1.83 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 25 Aug 2022 |
1y target est | N/A |
MIAMI BEACH, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) (“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2024. First Quarter Cases increased 2.9% over the prior year period to 3,746Revenue increased 3.9% over the prior year to $47.6 millionNet income of $6.0 million for the quarter compared to $(0.0) million in the prior year periodDiluted income per shar
MIAMI BEACH, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS), a national provider of premium body contouring procedures, today announced it will report first quarter 2024 financial results before market open on Friday, May 10, 2024, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference
AirSculpt® Technologies, Inc., ("AirSculpt") (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced the relocation of its Atlanta office to 3391 Peachtree Road NE Suite 100, Atlanta, GA 30326 from 3495 Piedmont Road. Also, the company's popular AirSculpt®+ skin tightening procedure has been added to the clinic's list of current offerings.